Considering the concurrent expression of CD38 and PD-1 on HCC CD8+ TILs and its association with the higher HCC histological grades in our HCC cohort, targeting CD38 in combination with PD-1 blockade could revive the cytotoxic function of exhausted CD8+ TRM cells. This evidence concerns the gene CD8A and hepatocellular carcinoma.